Spinner, M. A., Sica, R. A., Tamaresis, J. S., Lu, Y., Chang, C., Lowsky, R., . . . Arai, S. (2023). Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. Blood, 141(22), 2727-2737. https://doi.org/10.1182/blood.2022018827
Chicago Style (17th ed.) CitationSpinner, Michael A., et al. "Improved Outcomes for Relapsed/refractory Hodgkin Lymphoma After Autologous Transplantation in the Era of Novel Agents." Blood 141, no. 22 (2023): 2727-2737. https://doi.org/10.1182/blood.2022018827.
MLA (8th ed.) CitationSpinner, Michael A., et al. "Improved Outcomes for Relapsed/refractory Hodgkin Lymphoma After Autologous Transplantation in the Era of Novel Agents." Blood, vol. 141, no. 22, 2023, pp. 2727-2737, https://doi.org/10.1182/blood.2022018827.
Visit our Citation Styles guide for help on properly citing sources.